OBJECTIVE: Bloodstream infection (BSI) secondary to nosocomial urinary tract infection is associated with substantial morbidity, mortality, and additional financial costs. Our objective was to identify predictors of nosocomial urinary tract-related BSI. DESIGN: Matched case-control study. SETTING: Midwestern tertiary care hospital. PATIENTS: Cases (n=298) were patients with a positive urine culture obtained more than 48 hours after admission and a blood culture obtained within 14 days of the urine culture that grew the same organism. Controls (n=667), selected by incidence density sampling, included patients with a positive urine culture who were at risk for BSI but did not develop one. Methods. Conditional logistic regression and classification and regression tree analyses. RESULTS: The most frequently isolated microorganisms that spread from the urinary tract to the bloodstream were Enterococcus species. Independent risk factors included neutropenia (odds ratio [OR], 10.99; 95% confidence interval [CI], 5.78-20.88), renal disease (OR, 2.96; 95% CI, 1.98-4.41), and male sex (OR, 2.18; 95% CI, 1.52-3.12). The probability of developing a urinary tract-related BSI among neutropenic patients was 70%. Receipt of immunosuppressants (OR, 1.53; 95% CI, 1.04-2.25), insulin (OR, 4.82; 95% CI, 2.52-9.21), and antibacterials (OR, 0.66; 95% CI, 0.44-0.97) also significantly altered risk. CONCLUSIONS: The heightened risk of urinary tract-related BSI associated with several comorbid conditions suggests that the management of nosocomial bacteriuria may benefit from tailoring to certain patient subgroups. Consideration of time-dependent risk factors, such as medications, may also help guide clinical decisions in reducing BSI.
OBJECTIVE: Bloodstream infection (BSI) secondary to nosocomial urinary tract infection is associated with substantial morbidity, mortality, and additional financial costs. Our objective was to identify predictors of nosocomial urinary tract-related BSI. DESIGN: Matched case-control study. SETTING: Midwestern tertiary care hospital. PATIENTS: Cases (n=298) were patients with a positive urine culture obtained more than 48 hours after admission and a blood culture obtained within 14 days of the urine culture that grew the same organism. Controls (n=667), selected by incidence density sampling, included patients with a positive urine culture who were at risk for BSI but did not develop one. Methods. Conditional logistic regression and classification and regression tree analyses. RESULTS: The most frequently isolated microorganisms that spread from the urinary tract to the bloodstream were Enterococcus species. Independent risk factors included neutropenia (odds ratio [OR], 10.99; 95% confidence interval [CI], 5.78-20.88), renal disease (OR, 2.96; 95% CI, 1.98-4.41), and male sex (OR, 2.18; 95% CI, 1.52-3.12). The probability of developing a urinary tract-related BSI among neutropenicpatients was 70%. Receipt of immunosuppressants (OR, 1.53; 95% CI, 1.04-2.25), insulin (OR, 4.82; 95% CI, 2.52-9.21), and antibacterials (OR, 0.66; 95% CI, 0.44-0.97) also significantly altered risk. CONCLUSIONS: The heightened risk of urinary tract-related BSI associated with several comorbid conditions suggests that the management of nosocomial bacteriuria may benefit from tailoring to certain patient subgroups. Consideration of time-dependent risk factors, such as medications, may also help guide clinical decisions in reducing BSI.
Authors: Grazielle Cerqueira de Carvalho; Catarina de Andrade Regis; Jamile Rosário Kalil; Liv Aparício Cerqueira; Daniel Silva Barbosa; Marina Pamponet Motta; Marília da Silva Nery; Maria Alice Pires Soares; Claudio Celestino Zollinger; Paulo Lisboa Bittencourt Journal: Ann Hepatol Date: 2012 Jan-Feb Impact factor: 2.400
Authors: Marc W Merx; Elisa A Liehn; Uwe Janssens; Rudolf Lütticken; Jürgen Schrader; Peter Hanrath; Christian Weber Journal: Circulation Date: 2004-05-03 Impact factor: 29.690
Authors: M Todd Greene; Sanjay Saint; David Ratz; Latoya Kuhn; Jennifer Davis; Payal K Patel; Mary A M Rogers Journal: Am J Infect Control Date: 2018-11-20 Impact factor: 2.918
Authors: Payal K Patel; M Todd Greene; Mary A M Rogers; David Ratz; Latoya Kuhn; Jennifer Davis; Sanjay Saint Journal: Am J Infect Control Date: 2018-03-13 Impact factor: 2.918
Authors: M Todd Greene; David Ratz; Jennifer Meddings; Mohamad G Fakih; Sanjay Saint Journal: Infect Control Hosp Epidemiol Date: 2016-01-18 Impact factor: 3.254